2020
DOI: 10.1097/mph.0000000000001442
|View full text |Cite
|
Sign up to set email alerts
|

Development of Secondary Osteosarcoma After TBI and Allogeneic Bone Marrow Transplant: A Case Series of 3 Patients

Abstract: Osteosarcoma can rarely occur as a subsequent malignant neoplasm after cancer therapy. Children who underwent treatment for cancer and received an allogeneic hematopoietic cell transplant are at a higher risk to develop secondary malignancies. Radiation is also a known risk factor, but estimating the quantitative risk is difficult due to the rarity of the condition and long latency period between primary and secondary cancer. In this report, we present 3 patients diagnosed with leukemia as young children who r… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
5
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(5 citation statements)
references
References 18 publications
0
5
0
Order By: Relevance
“…23 Second tumors are an important complication of BMT, but secondary osteosarcoma has rarely been reported in this setting. [4][5][6][7][8][9][10][11][12][13][14] The few reports on the outcome of osteosarcoma after ALL and/or BMT suggest that this is an aggressive tumor with a poor prognosis. We found 21 cases of osteosarcoma secondary to allogeneic BMT in the literature.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…23 Second tumors are an important complication of BMT, but secondary osteosarcoma has rarely been reported in this setting. [4][5][6][7][8][9][10][11][12][13][14] The few reports on the outcome of osteosarcoma after ALL and/or BMT suggest that this is an aggressive tumor with a poor prognosis. We found 21 cases of osteosarcoma secondary to allogeneic BMT in the literature.…”
Section: Discussionmentioning
confidence: 99%
“…We found 21 cases of osteosarcoma secondary to allogeneic BMT in the literature. [4][5][6][7][8][9][10][11][12][13][14] The median age at diagnosis was 15 years (range 7-26 years). The reason for BMT was ALL in 13 patients, whereas the others were single cases of acute myeloid leukemia, neuroblastoma, chronic granulomatous disease, Blackfan-Diamond anemia, congenital amegakaryocytic thrombocytopenia, myelodysplastic syndrome, and non-Hodgkin lymphoma.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…The worst prognosis of SO mainly stems from its typical characteristics, which consist of local invasion, high-grade and distant metastasis, as well as not-in-time treatment and the intolerance of patients 8 . In addition, the prior malignancy history may make it more complicated to conform diagnosis and accurate fight against osteosarcoma cells 9 12 . To conclude, SO could pose a great challenge to long-term survival.…”
Section: Introductionmentioning
confidence: 99%
“…To our knowledge, there is few research on the surgery compliance of SO. Only a few case studies have been done in previous literature 9 11 . Other studies with slightly larger samples focused on the overall assessment and did not specifically reveal determinants of surgical compliance 13 , 14 .…”
Section: Introductionmentioning
confidence: 99%